Health Professionals Hail FDA Approval of Treatment for Excessive Drooling Adults with Neurological Disorders
The medical community has recently hailed the Food and Drugs Administration over its decision to approve treatments for adult patients with neurological disorders who experience excessive drooling, a report read.
“This approval represents a significant milestone in addressing the unmet needs for more than 600,000 adults who suffer from chronic sialorrhea, and underscores our commitment to improving the lives of those living with movement disorders,” said Kevin O’Brien, vice president and US Head of Neurosciences for Merz North America in a report.
For the longest time, health professionals have been pushing for the treatment of excessive drooling for adults with neurological disorders such as cerebral palsy, describing it as a “distressing symptom.”
A report said that certain medi...